3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Stomach Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatectomy
1
Heart Defects, Congenital
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Psychiatric Rehabilitation
7
Flow Cytometry
6
Therapeutics
5
Surveys and Questionnaires
5
Microarray Analysis
5
Gene Expression Profiling
5
Vincristine
4
Polymerase Chain Reaction
4
Methotrexate
4
Daunorubicin
4
Cytogenetic Analysis
4
Amplified Fragment Length Polymorphism Analysis
4
ponatinib
3
fludarabine
3
Watchful Waiting
3
Prednisone
3
Observation
3
Mercaptopurine
3
Interviews as Topic
3
Inotuzumab Ozogamicin
3
Immunologic Techniques
3
Immunoenzyme Techniques
3
Cytarabine
3
Cyclophosphamide
3
tisagenlecleucel
2
pegaspargase
2
fish oil triglycerides
2
blinatumomab
2
In Situ Hybridization, Fluorescence
2
Imatinib Mesylate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Enhanced Recovery After Surgery
×
Clear all
NCT05665712
2023-10-05
PERCS
University of Alberta
Completed
483 enrolled